Pharmacy- Page 28

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Allergan and Editas Medicine Enter into Strategic R&D Alliance

The FINANCIAL -- Allergan plc and Editas Medicine, Inc. on March 14 announced that Allergan's wholly-owned subsidiary, Allergan Pharmaceuticals International Limited, and Editas Medicine have entered into a strategic research and development alliance under which Allergan will receive exclusive access and the

by The FINANCIAL

March 14, 2017

1 min read

Pharmacy

INCJ, Takeda, and MEDIPAL HOLDINGS Partner to Launch a Biotech Venture

The FINANCIAL -- Innovation Network Corporation of Japan, Takeda Pharmaceutical Company Limited and MEDIPAL HOLDINGS CORPORATION have agreed to jointly invest a total of 10 billion yen to establish a new company, which will be named SCOHIA PHARMA, Inc..

by The FINANCIAL

March 14, 2017

2 mins read

Pharmacy

Novartis Kisqali Gets FDA Approval To Treat HR+/HER2- Metastatic Breast Cancer

The FINANCIAL -- The US Food and Drug Administration (FDA) has approved Kisqali (ribociclib, formerly known as LEE011) in combination with an aromatase inhibitor as initial endocrine-based therapy for treatment of postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2

by The FINANCIAL

March 14, 2017

2 mins read

Pharmacy

Change in Novo Nordisk Executive Management

The FINANCIAL -- Novo Nordisk A/S on March 1 announced that Jakob Riis, executive vice president, head of North America Operations and president of Novo Nordisk Inc. has resigned from the company.

by The FINANCIAL

March 2, 2017

1 min read

Pharmacy

Lilly Announces Changes in Senior Management

The FINANCIAL -- Eli Lilly and Company on March 2 announced changes in its executive committee.

by The FINANCIAL

March 2, 2017

2 mins read

Pharmacy

Bushu and Takeda Announce Transformational Pharmaceutical Sciences Partnership

The FINANCIAL -- Bushu Pharmaceuticals Limited and Takeda Pharmaceutical Company Limited announced on February 28 that the companies have entered into a new partnership agreement under which Takeda will transfer a part of its Pharmaceutical Sciences/CMC business to Bushu.

by The FINANCIAL

February 28, 2017

1 min read

Pharmacy

Kyowa and Astellas enter into an Agreement

The FINANCIAL -- Kyowa Pharmaceutical Industry Co., Ltd. and Astellas Pharma Inc. on February 27 announced that the companies have entered into an agreement providing Kyowa the exclusive right to distribute and promote extended-release tablets of quetiapine fumarate in Japan.

by The FINANCIAL

February 27, 2017

1 min read

Pharmacy

Sanofi and Lonza Enter into a Strategic Partnership

The FINANCIAL -- Sanofi and Lonza announced on February 27 that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.

by The FINANCIAL

February 27, 2017

2 mins read

Pharmacy

Johnson & Johnson Completes Acquisition of Abbott Medical Optics

The FINANCIAL -- Johnson & Johnson on February 27 announced it has completed the acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott.

by The FINANCIAL

February 27, 2017

1 min read

Pharmacy

PRA Health Sciences and Takeda Partnership Expands to Japan

The FINANCIAL -- PRA Health Sciences, Inc. and Takeda Pharmaceutical Company Limited announced on February 15 that they have agreed to a new partnership to expand their global relationship initially disclosed in September 2016 to include Japan.

by The FINANCIAL

February 15, 2017

1 min read